These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 32812206)

  • 1. Clinical Impact of Weight-Loss Pharmacotherapy in Patients with Atherosclerotic Cardiovascular Disease.
    Pirlet C; Poirier P; Cieza T; Piché ME; Biertho L; Maes F; Ruzsa Z; Bertrand OF
    Am J Cardiovasc Drugs; 2021 May; 21(3):271-281. PubMed ID: 32812206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weight management and current options in pharmacotherapy: orlistat and sibutramine.
    Leung WY; Thomas GN; Chan JC; Tomlinson B
    Clin Ther; 2003 Jan; 25(1):58-80. PubMed ID: 12637112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug treatment of obesity in cardiovascular disease.
    Charakida M; Finer N
    Am J Cardiovasc Drugs; 2012 Apr; 12(2):93-104. PubMed ID: 22292446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacotherapy for the treatment of obesity.
    Sweeting AN; Hocking SL; Markovic TP
    Mol Cell Endocrinol; 2015 Dec; 418 Pt 2():173-83. PubMed ID: 26360586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of glucagon-like peptide 1 receptor agonists in management of obesity.
    Isaacs D; Prasad-Reddy L; Srivastava SB
    Am J Health Syst Pharm; 2016 Oct; 73(19):1493-507. PubMed ID: 27521241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapy of obesity: Available medications and drugs under investigation.
    Pilitsi E; Farr OM; Polyzos SA; Perakakis N; Nolen-Doerr E; Papathanasiou AE; Mantzoros CS
    Metabolism; 2019 Mar; 92():170-192. PubMed ID: 30391259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term pharmacotherapy for obesity and overweight.
    Padwal R; Li SK; Lau DC
    Cochrane Database Syst Rev; 2003; (4):CD004094. PubMed ID: 14584004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging pharmacotherapy for treating obesity and associated cardiometabolic risk.
    Caterson ID; Finer N
    Asia Pac J Clin Nutr; 2006; 15 Suppl():55-62. PubMed ID: 16928662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination phentermine and topiramate extended release in the management of obesity.
    Alfaris N; Minnick AM; Hopkins CM; Berkowitz RI; Wadden TA
    Expert Opin Pharmacother; 2015 Jun; 16(8):1263-74. PubMed ID: 25958964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term pharmacotherapy for obesity.
    Klein S
    Obes Res; 2004 Dec; 12 Suppl():163S-6S. PubMed ID: 15687412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of Obesity and Pharmacologic Treatment Options.
    Shettar V; Patel S; Kidambi S
    Nutr Clin Pract; 2017 Aug; 32(4):441-462. PubMed ID: 28632997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacotherapy of Obesity: Clinical Trials to Clinical Practice.
    Gadde KM; Pritham Raj Y
    Curr Diab Rep; 2017 May; 17(5):34. PubMed ID: 28378293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do we need anti-obesity drugs?
    Hainer V; Hainerová IA
    Diabetes Metab Res Rev; 2012 Dec; 28 Suppl 2():8-20. PubMed ID: 23280861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of weight management interventions that include a diet component on weight-related outcomes in pregnant and postpartum women: a systematic review protocol.
    Spencer L; Rollo M; Hauck Y; MacDonald-Wicks L; Wood L; Hutchesson M; Giglia R; Smith R; Collins C
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):88-98. PubMed ID: 26447010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overweight and obesity: pharmacotherapeutic considerations.
    Balkon N; Balkon C; Zitkus BS
    J Am Acad Nurse Pract; 2011 Feb; 23(2):61-6. PubMed ID: 21281371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of pharmacological obesity treatments: focus on adverse side-effect profiles.
    Krentz AJ; Fujioka K; Hompesch M
    Diabetes Obes Metab; 2016 Jun; 18(6):558-70. PubMed ID: 26936802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity pharmacotherapy from a regulatory perspective: overview and key challenges.
    Hutchinson NI; Ryder SW
    Clin Pharmacol Ther; 2007 May; 81(5):756-60. PubMed ID: 17392723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treating the Chronic Disease of Obesity.
    Gossmann M; Butsch WS; Jastreboff AM
    Med Clin North Am; 2021 Nov; 105(6):983-1016. PubMed ID: 34688422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacotherapy for Patients with Obesity.
    Gadde KM; Apolzan JW; Berthoud HR
    Clin Chem; 2018 Jan; 64(1):118-129. PubMed ID: 29054924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.